Overview Metformin ER 750 mg Tablets, Fasting Status: Completed Trial end date: 2003-08-01 Target enrollment: Participant gender: Summary The objective of this study is to compare the rate and extent of absorption of metformin from a test formulation of Metformin ER 750 mg Tablets versus the reference Glucophage® XR 750 mg Tablets under fasting conditions. Phase: Phase 1 Details Lead Sponsor: Teva Pharmaceuticals USATreatments: Metformin